leisure time -WSS

leisure time

author：fashion 2025-10-01 04:13:37 - browse：37461

Lauren Gavron walking with prosthetic in a lab at the University of Pittsburgh. Courtesy Nathan Langer/UPMC & Pitt Health Sciences

For years, Lauren Gavron relied on oxycodone to quiet the pain in her missing lower left limb. But she hated the fog that came with it, preventing her from feeling comfortable enough to drive.

When researchers at the University of Pittsburgh delivered electric jolts to her spine in 2021, the Duquesne, Pennsylvania resident was shocked to feel that pain temporarily melt away — and to feel sensation in her prosthetic foot, improving her walk and balance.

“You really wouldn’t believe it,” Gavron, 67, said. “As soon as the pain would start, it just all went away.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： As Maui death toll rises, number of missing remains unclear

WSS

An interview with Robert F. Kennedy Jr. on vaccines

Hilary expected to bring catastrophic, life

An interview with Robert F. Kennedy Jr. on vaccines

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Readout Newsletter: BridgeBio, Akero, and human embryo models

Clinical trials must include more disabled people

knowledge

leisure time

hotspot

Psychedelics group wrestles with new pharma identity

He's 19 months old and has one of the world’s rarest diseases

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ActiGraph execs on goal of drug approvals with digital endpoints

How one medical school became remarkably diverse

Hilary may become 1st tropical storm to make landfall in California in 84 years

After affirmative action ruling, medical educators look to 'holistic review'

Hilary may become 1st tropical storm to make landfall in California in 84 years

Hollywood unions extend contract negotiations for actors

Longer MASH drug regimen improved liver, Akero study finds

leisure time

Readout Newsletter: BridgeBio, Akero, and human embryo models

Why Talkspace is targeting Medicare, a tricky market

FDA approves first treatment for ultra

Lung cancer is America's deadliest cancer. Yet so few get screened

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Harvard's David Sinclair gets blowback over aging

leisure time

explore

entertainment

leisure time